Skip to main content

Adult and Pediatric Hemoconcentrators Market Demands and Gross Margin 2028

 


A hemoconcentrator is a device used for removal of fluid during cardio bypass surgery. Hemoconcentrators are introduced in extracorpeal circuit where it controls hemodilution, maintains hematocrit levels, and reduces the need for additional blood products during and after surgery. Hemoconcentrators are widely used during cardiac bypass surgery and has become the ideal method for controlling hemodilution during cardiopulmonary surgery by surgeons and perfusionists.

High prevalence of cardiovascular diseases is expected to lead to high demand for hemoconcentrators and thus drive the adult and pediatric hemoconcentrators market growth

Hemoconcentrators are widely used devices during cardio bypass surgery. High prevalence of cardiovascular diseases is expected to be a major factor propelling demand for hemoconcentrator. According to the data published by World Health Organization (WHO) in 2017, cardiovascular diseases is the leading cause of death globally. Annually, more people die from cardiovascular diseases than from any other cause.

According to the data published by World Health Organization (WHO) in 2018, an estimated around 17.7 million people died from cardiovascular diseases in 2015, representing 31% of all global deaths. Such high prevalence of cardiovascular diseases is expected to lead to high demand for hemoconcentrators and drive global adult and pediatric hemoconcentrators market growth over the forecast period.

Key players in the market include Terumo Corporation, LivaNova Plc., Medtronic Plc., etc. All these key players manufacture and market their own novel hemoconcentrators developed from different materials with different advantages. For instance, in 2011 Minntech Corporation (a Cantel Medical Corporation company) introduced The Hemocor HPH Hemoconcentrator made with Eastman Chemical Company’s Tritan Copolyester. Tritan is a new-generation copolyester that offers the benefits of toughness, chemical resistance, and color stability after sterilization for renal medical device housings.

The global adult and pediatric hemoconcentrators market size was valued at US$ 10.7 Mn in 2017, and is expected to witness a CAGR of 3.3% during the forecast period (2018 – 2026).

North America is expected to hold dominant position in the market, owing to frequent approvals of new adult and pediatric hemoconcentrators by regulatory bodies

North America is expected to hold dominant position in global adult and pediatric hemoconcentrators market over the forecast period, owing to high prevalence of cardiovascular diseases in the U.S. and rising healthcare awareness in region.

 

Labels:

Comments

Post a Comment

Popular posts from this blog

The Global Pressure Bandages Market Is Witnessing High Growth Owing To the Increasing Incidence of Surgical Processes in the World

  Market Overview: During a medical emergency, a pressure bandage is used to apply pressure to an area of the body to control bleeding and swelling. There are a variety of types of pressure bandages that can be used for different purposes. The bandage is made up of several parts, including an air bladder, a pad, a closure bar, and an applicator. A pressure bandage can be applied to wounds at any location on the body. This type of dressing is useful in treating various conditions, including gunshot wounds. It can also be used for a temporary holding of a hernia. The bandage is usually vacuum-sealed, so it's easier to carry. Competitive Landscape: Major players operating in the global pressure bandages market include ConvaTec Group PLC., Cardinal Health, 3M, B. Braun Melsungen AG, Lohmann & Rauscher GmbH & Co. KG, Mölnlycke Health Care AB, Smith & Nephew plc., Paul Hartmann AG, and Essity (BSN medical GmbH). Key Market Drivers: Increasing developments by key pla...
Post a Comment
Read more

Custom Antibody Service Market Segmentation Application, Technology and Market Analysis to 2028

  The immune system produces antibodies in response to pathogen invasion. Antigens are the collective term for the invasive bacteria, viruses, or other foreign molecules. Antibodies are proteins, or polypeptides which have specific antigen recognition sites. It is possible to have antibodies made using custom antibody production when an antibody is required against a particular antigen but it is not offered by a supplier. These antibodies can be either polyclonal or monoclonal, depending on how they are produced and harvested. Polyclonal  antibodies  are capable of recognizing multiple sites on an antigen. They are derived from different B-cell lineages. Monoclonal antibodies recognize only one epitope or site on an antigen, and are derived from a single B-cell line. Global custom antibody service market is estimated to be valued at  US$ 444.85 Million in 2022  and expected to reach  US$ 930.46 million by 2030 , witnessing a  CAGR of 9.7 %  over...
Post a Comment
Read more

Increasing Incidences of Infectious Diseases to Augment the Antibacterial Drugs Market Growth

  Antibacterial drugs are widely used to treat and prevent infectious diseases and are categorized into seven major classes, such as β-Lactams, phenicols, macrolides, quinolones, sulfonamides, tetracyclines, and aminoglycosides, based on their molecular structure. Antibacterial drugs destroy or slow down the growth of bacteria. These medications are also used to treat urinary infections caused by S. aureus, E. coli, Streptococcus pyogenes, and other bacterial infections. They include a range of powerful drugs used to treat diseases caused by bacteria. Antibiotics cannot treat viral infections, such as cold, flu, and most coughs. Antibacterial drugs play a major role in advanced healthcare, as they are widely used to treat infectious diseases, such as tuberculosis, malaria, typhoid, leprosy, hepatitis B, HIV/AIDS, and others. Thus, there is an increasing demand for antibacterial drugs worldwide.  
Post a Comment
Read more